CSIMarket
 
Aerie Pharmaceuticals Inc   (NASDAQ: AERI)
 

Aerie Pharmaceuticals Inc's Suppliers Performance

AERI's Supply Chain




 
AERI Costs vs Sales of Suppliers Growth Aerie Pharmaceuticals Inc's cost of sales deteriorated by -12.28 % year on year, sequentially cost of sales grew by 85.22 % in Q3.

• More on AERI Suppliers



Aerie Pharmaceuticals Inc's cost of sales deteriorated by -12.28 % year on year, sequentially cost of sales grew by 85.22 % in Q3.

• More on AERI Suppliers




Aerie Pharmaceuticals Inc's Comment on Supply Chain









AERI's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Aerie Pharmaceuticals Inc 729.25 213.94 -36.55 259
SUBTOTAL 0.00 0.00 0.00 -


Sources: Aerie Pharmaceuticals Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Aerie Pharmaceuticals Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.